Study finds mRNA vaccines lead to increase of serious adverse events
A new study has found that the Pfizer and Moderna mRNA vaccines were associated with “an increased risk of serious adverse events of special interest” that likely outweighs any benefit of taking them.
FDA authorizes mRNA COVID vaccine for babies
Following a unanimous vote from independent advisors, the FDA has authorized the Pfizer and Moderna COVID vaccines for babies aged six months and up under ’emergency use.’
Neither the Pfizer nor Moderna mRNA vaccines are effective at protecting against COVID
Studies have found that both the Pfizer and Moderna vaccines offer almost no protection against COVID over time, particularly against the Omicron variant.
New study finds Moderna vaccinated more likely to be reinfected
A new study on the efficacy of the Moderna vaccine has found that recipients are more likely to lack antibodies crucial to preventing repeat infection compared to those with natural immunity.
Novavax is developing a two-in-one COVID flu vaccine
Pharmaceutical giant Novavax is developing a two-in-one COVID/flu vaccine.
Modern CEO says 4th shot will be required
While speaking at a Goldman-Sachs-organized health care event, Moderna CEO Stephane Bancel said that an additional booster shot, a fourth dose of the COVID vaccine, will likely be necessary by Fall 2022, adding that ongoing booster shots are probable.